Curebound 2023 grant recipient Andrew Lowy, MD, PhD, on the recent Cure Prize project and the potential effect it will have on the standard of care in pancreatic cancer patients. “My career has been dedicated to the care and cure of patients with pancreatic cancer. Our project builds on our team's discovery that blocking the function of Syk Kinase can engender an antitumor immune response to pancreatic cancer and enhance the effects of chemotherapy. We are incredibly excited to test this idea in pancreatic cancer patients who will undergo surgery. Curebound‘s support will make it possible for us to study the effectiveness of this approach in patients and to understand the science behind it. As the drug we will use is already FDA approved for other indications, if the successful, our study could result in a rapid change to the standard of care for pancreatic cancer patients.” - Andrew Lowy, MD, PhD UC San Diego Health curebound.org UC San Diego Health Salk Institute for Biological Studies Photo Credit: UC San Diego Health
Congratulations, Dr. Lowy!
Outstanding! Congratulations, Dr. Lowry! 💫
Congratulations Dr. Lowy!
Congratulations Dr.Lowy
Owner, Broker, Realtor | Luxury Real Estate in San Diego | ADUs | Listing Renovations |Locally-Owned| UCSD Alumni
1moCongratulations Dr Lowy 😊